Jackson Grant Investment Advisers’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39K Hold
20
﹤0.01% 379
2025
Q4
$2.72K Hold
20
﹤0.01% 375
2025
Q3
$2.95K Hold
20
﹤0.01% 382
2025
Q2
$2.59K Hold
20
﹤0.01% 358
2025
Q1
$2.39K Hold
20
﹤0.01% 353
2024
Q4
$2.32K Hold
20
﹤0.01% 366
2024
Q3
$2.7K Hold
20
﹤0.01% 361
2024
Q2
$2.71K Hold
20
﹤0.01% 354
2024
Q1
$2.58K Hold
20
﹤0.01% 349
2023
Q4
$2.29K Hold
20
﹤0.01% 348
2023
Q3
$1.82K Hold
20
﹤0.01% 353
2023
Q2
$2.25K Hold
20
﹤0.01% 363
2023
Q1
$2.09K Buy
+20
New +$2.09K ﹤0.01% 386

Other funds holding XYL

Jackson Grant Investment Advisers's XYL Position: Q1 2026 in Review

Jackson Grant Investment Advisers held its Xylem (XYL) position steady in Q1 2026 at 20 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

Jackson Grant Investment Advisers first reported a position in XYL in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.95K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Jackson Grant Investment Advisers held 20 shares of Xylem worth $2.39K as of Q1 2026.
  • Jackson Grant Investment Advisers left its Xylem share count unchanged in Q1 2026.
  • Xylem made up ﹤0.01% of Jackson Grant Investment Advisers's portfolio in Q1 2026, its #379 holding.
  • Jackson Grant Investment Advisers first reported a position in Xylem in Q1 2023 and has held it in 13 quarters since.
  • Jackson Grant Investment Advisers's Xylem position peaked at $2.95K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q1 2026, filed 8 May 2026.